PubRank

Dieter Felsenberg

Author PubWeight™ 114.57‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 2007 6.76
2 Intravenous zoledronic acid in postmenopausal women with low bone mineral density. N Engl J Med 2002 5.83
3 Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res 2004 4.04
4 Intravenous ibandronate injections in postmenopausal women with osteoporosis: one-year results from the dosing intravenous administration study. Arthritis Rheum 2006 2.82
5 Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res 2015 2.74
6 Genome-wide association study using extreme truncate selection identifies novel genes affecting bone mineral density and fracture risk. PLoS Genet 2011 2.34
7 Clinical use of quantitative computed tomography and peripheral quantitative computed tomography in the management of osteoporosis in adults: the 2007 ISCD Official Positions. J Clin Densitom 2008 2.21
8 Association of five quantitative ultrasound devices and bone densitometry with osteoporotic vertebral fractures in a population-based sample: the OPUS Study. J Bone Miner Res 2004 2.01
9 Bone loss is detected more frequently in patients with ankylosing spondylitis with syndesmophytes. J Rheumatol 2005 1.84
10 Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study. J Bone Miner Res 2005 1.81
11 Muscle atrophy and bone loss after 90 days' bed rest and the effects of flywheel resistive exercise and pamidronate: results from the LTBR study. Bone 2005 1.65
12 Risedronate prevents new vertebral fractures in postmenopausal women at high risk. J Clin Endocrinol Metab 2003 1.65
13 Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial. Arthritis Rheum 2008 1.51
14 Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis. Calcif Tissue Int 2011 1.50
15 Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis. Bone 2008 1.44
16 Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD. J Bone Miner Res 2005 1.39
17 Acute changes in neuromuscular excitability after exhaustive whole body vibration exercise as compared to exhaustion by squatting exercise. Clin Physiol Funct Imaging 2003 1.39
18 Characteristics of a prevalent vertebral deformity predict subsequent vertebral fracture: results from the European Prospective Osteoporosis Study (EPOS). Bone 2003 1.37
19 Vascular adaptation to deconditioning and the effect of an exercise countermeasure: results of the Berlin Bed Rest study. J Appl Physiol (1985) 2005 1.36
20 Bone mineral density in relation to efficacy and side effects of budesonide and prednisolone in Crohn's disease. Clin Gastroenterol Hepatol 2005 1.29
21 Is muscle power output a key factor in the age-related decline in physical performance? A comparison of muscle cross section, chair-rising test and jumping power. Clin Physiol Funct Imaging 2004 1.28
22 Efficacy of risedronate on clinical vertebral fractures within six months. Curr Med Res Opin 2004 1.28
23 Increase in vertebral fracture risk in postmenopausal women using omeprazole. Calcif Tissue Int 2008 1.26
24 Intravenous pamidronate prevents femoral bone loss and renal stone formation during 90-day bed rest. J Bone Miner Res 2004 1.26
25 When should the doctor order a spine X-ray? Identifying vertebral fractures for osteoporosis care: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res 2004 1.24
26 Treatment of chronic lower back pain with lumbar extension and whole-body vibration exercise: a randomized controlled trial. Spine (Phila Pa 1976) 2002 1.23
27 Bisphosphonates in the management of postmenopausal osteoporosis--optimizing efficacy in clinical practice. Clin Interv Aging 2008 1.22
28 Thyroid function within the upper normal range is associated with reduced bone mineral density and an increased risk of nonvertebral fractures in healthy euthyroid postmenopausal women. J Clin Endocrinol Metab 2010 1.21
29 Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study. J Rheumatol 2008 1.18
30 Impact of bed rest on conduit artery remodeling: effect of exercise countermeasures. Hypertension 2010 1.17
31 Therapy insight: the risks and benefits of bisphosphonates for the treatment of tumor-induced bone disease. Nat Clin Pract Oncol 2007 1.17
32 Reproducibility of the jumping mechanography as a test of mechanical power output in physically competent adult and elderly subjects. J Am Geriatr Soc 2004 1.11
33 Strontium ranelate and alendronate have differing effects on distal tibia bone microstructure in women with osteoporosis. Rheumatol Int 2010 1.09
34 Added value of trabecular bone score to bone mineral density for prediction of osteoporotic fractures in postmenopausal women: the OPUS study. Bone 2013 1.05
35 Long term bed rest with and without vibration exercise countermeasures: effects on human muscle protein dysregulation. Proteomics 2010 1.02
36 Ryanodine receptor type-1 (RyR1) expression and protein S-nitrosylation pattern in human soleus myofibres following bed rest and exercise countermeasure. Histochem Cell Biol 2008 1.00
37 WISE-2005: bed-rest induced changes in bone mineral density in women during 60 days simulated microgravity. Bone 2011 1.00
38 Countermeasures against lumbar spine deconditioning in prolonged bed rest: resistive exercise with and without whole body vibration. J Appl Physiol (1985) 2010 0.99
39 Alendronate with and without cholecalciferol for osteoporosis: results of a 15-week randomized controlled trial. Curr Med Res Opin 2006 0.99
40 Differential atrophy of the lower-limb musculature during prolonged bed-rest. Eur J Appl Physiol 2009 0.99
41 Human skeletal muscle structure and function preserved by vibration muscle exercise following 55 days of bed rest. Eur J Appl Physiol 2006 0.97
42 Prevention of bone loss during 56 days of strict bed rest by side-alternating resistive vibration exercise. Bone 2009 0.96
43 Detrimental effect of oral contraceptives on parameters of bone mass and geometry in a cohort of 248 young women. Bone 2006 0.95
44 Risedronate slows or partly reverses cortical and trabecular microarchitectural deterioration in postmenopausal women. J Bone Miner Res 2014 0.93
45 Trabecular and cortical bone density and architecture in women after 60 days of bed rest using high-resolution pQCT: WISE 2005. J Bone Miner Res 2011 0.93
46 No influence of age, gender, weight, height, and impact profile in achilles tendinopathy in masters track and field athletes. Am J Sports Med 2009 0.92
47 Comparison of change in bone resorption and bone mineral density with once-weekly alendronate and daily risedronate: a randomised, placebo-controlled study. Curr Med Res Opin 2003 0.92
48 Muscle atrophy and changes in spinal morphology: is the lumbar spine vulnerable after prolonged bed-rest? Spine (Phila Pa 1976) 2011 0.92
49 Heterogeneous atrophy occurs within individual lower limb muscles during 60 days of bed rest. J Appl Physiol (1985) 2012 0.92
50 Changes in intervertebral disc morphology persist 5 mo after 21-day bed rest. J Appl Physiol (1985) 2011 0.91
51 Magnetic resonance imaging assessment of trunk muscles during prolonged bed rest. Spine (Phila Pa 1976) 2007 0.91
52 Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density. J Clin Endocrinol Metab 2009 0.91
53 Disease-specific risk for an osteonecrosis of the jaw under bisphosphonate therapy. J Cancer Res Clin Oncol 2009 0.90
54 The effects of rehabilitation on the muscles of the trunk following prolonged bed rest. Eur Spine J 2010 0.89
55 Effects of denosumab on the geometry of the proximal femur in postmenopausal women in comparison with alendronate. J Clin Densitom 2008 0.88
56 Bed rest and cognition: effects on executive functioning and reaction time. Aviat Space Environ Med 2009 0.88
57 Age at first oral contraceptive use as a major determinant of vertebral bone mass in female endurance athletes. Bone 2004 0.86
58 Impact of oral ibandronate 150 mg once monthly on bone structure and density in post-menopausal osteoporosis or osteopenia derived from in vivo μCT. Bone 2011 0.86
59 Bone mineral density and bone turnover in male masters athletes aged 40-64. Aging Male 2010 0.86
60 Effects of intermittent intravenous ibandronate injections on bone quality and micro-architecture in women with postmenopausal osteoporosis: the DIVA study. Bone 2009 0.84
61 Secondary osteoporosis: endocrine and metabolic causes of bone mass deterioration. J Osteoporos 2012 0.84
62 Performance evaluation of automated assays for beta-CrossLaps, N-MID-Osteocalcin and intact parathyroid hormone (BIOROSE Multicenter Study). Clin Chem Lab Med 2004 0.84
63 Hypertrophy in the cervical muscles and thoracic discs in bed rest? J Appl Physiol (1985) 2013 0.84
64 Incomplete recovery of lumbar intervertebral discs 2 years after 60-day bed rest. Spine (Phila Pa 1976) 2012 0.84
65 Knee extensor fatigability after bedrest for 8 weeks with and without countermeasure. Muscle Nerve 2007 0.83
66 Influence of vibration resistance training on knee extensor and plantar flexor size, strength, and contractile speed characteristics after 60 days of bed rest. J Appl Physiol (1985) 2009 0.83
67 Decision making after 50 days of simulated weightlessness. Brain Res 2009 0.83
68 Tree-structured subgroup analysis of receiver operating characteristic curves for diagnostic tests. Acad Radiol 2012 0.83
69 Expression and regulation of Homer in human skeletal muscle during neuromuscular junction adaptation to disuse and exercise. FASEB J 2011 0.83
70 Localization and Segmentation of 3D Intervertebral Discs in MR Images by Data Driven Estimation. IEEE Trans Med Imaging 2015 0.82
71 Resistive simulated weightbearing exercise with whole body vibration reduces lumbar spine deconditioning in bed-rest. Spine (Phila Pa 1976) 2008 0.82
72 A new concept for bisphosphonate therapy: a rationale for the development of monthly oral dosing of ibandronate. Osteoporos Int 2005 0.82
73 The effect of bed rest and an exercise countermeasure on leg venous function. Eur J Appl Physiol 2008 0.82
74 Differential atrophy of the postero-lateral hip musculature during prolonged bedrest and the influence of exercise countermeasures. J Appl Physiol (1985) 2011 0.82
75 Patellar tendinopathy in master track and field athletes: influence of impact profile, weight, height, age and gender. Knee Surg Sports Traumatol Arthrosc 2010 0.81
76 Safety and tolerability of oral daily and intermittent ibandronate are not influenced by age. J Rheumatol 2005 0.81
77 Tonic-to-phasic shift of lumbo-pelvic muscle activity during 8 weeks of bed rest and 6-months follow up. J Appl Physiol (1985) 2007 0.81
78 Resistive exercise versus resistive vibration exercise to counteract vascular adaptations to bed rest. J Appl Physiol (1985) 2009 0.81
79 Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg 2008 0.81
80 Superficial lumbopelvic muscle overactivity and decreased cocontraction after 8 weeks of bed rest. Spine (Phila Pa 1976) 2007 0.80
81 Three-dimensional quantification of structures in trabecular bone using measures of complexity. Phys Rev E Stat Nonlin Soft Matter Phys 2009 0.80
82 Resistive exercises, with or without whole body vibration, prevent vertebral marrow fat accumulation during 60 days of head-down tilt bed rest in men. J Appl Physiol (1985) 2012 0.79
83 Vertical jump performance after 90 days bed rest with and without flywheel resistive exercise, including a 180 days follow-up. Eur J Appl Physiol 2007 0.79
84 Effect of raloxifene combined with monofluorophosphate as compared with monofluorophosphate alone in postmenopausal women with low bone mass: a randomized, controlled trial. Osteoporos Int 2003 0.79
85 Anatomical sector analysis of load-bearing tibial bone structure during 90-day bed rest and 1-year recovery. Clin Physiol Funct Imaging 2011 0.79
86 Comparative examination of human proximal tibiae in vitro by ultrasonic guided waves and pQCT. Ultrasound Med Biol 2011 0.79
87 Pattern of intravenous bisphosphonate use in outpatient care in Germany. Pharmacoepidemiol Drug Saf 2008 0.79
88 Muscle atrophy, pain, and damage in bed rest reduced by resistive (vibration) exercise. Med Sci Sports Exerc 2014 0.78
89 Short-duration resistive exercise sustains neuromuscular function after bed rest. Med Sci Sports Exerc 2012 0.78
90 Modification of a device and its application for intralesional cryosurgery of old recalcitrant keloids. Arch Dermatol 2004 0.78
91 Influence of prolonged bed-rest on spectral and temporal electromyographic motor control characteristics of the superficial lumbo-pelvic musculature. J Electromyogr Kinesiol 2010 0.78
92 Bone turnover and bone mineral density are independently related to selenium status in healthy euthyroid postmenopausal women. J Clin Endocrinol Metab 2012 0.78
93 Effect of prolonged bed rest on the anterior hip muscles. Gait Posture 2009 0.78
94 Nitrosative stress in human skeletal muscle attenuated by exercise countermeasure after chronic disuse. Redox Biol 2013 0.78
95 Resistive vibration exercise during bed-rest reduces motor control changes in the lumbo-pelvic musculature. J Electromyogr Kinesiol 2011 0.77
96 Osteonecrosis of the jaw after osteoporosis therapy with denosumab following long-term bisphosphonate therapy. Mayo Clin Proc 2013 0.77
97 Whole-body vibration versus proprioceptive training on postural control in post-menopausal osteopenic women. Gait Posture 2013 0.77
98 Progressive adaptation in physical activity and neuromuscular performance during 520d confinement. PLoS One 2013 0.77
99 Muscle X-ray attenuation is not decreased during experimental bed rest. Muscle Nerve 2013 0.77
100 Risk factors influencing the duration of treatment with bisphosphonates until occurrence of an osteonecrosis of the jaw in 963 cancer patients. J Cancer Res Clin Oncol 2014 0.76
101 THRA and DIO2 mutations are unlikely to be a common cause of increased bone mineral density in euthyroid post-menopausal women. Eur J Endocrinol 2014 0.76
102 Bisphosphonates and atypical femoral fractures. N Engl J Med 2010 0.76
103 Comparison of the skeletal effects of the progestogens desogestrel and levonorgestrel in oral contraceptive preparations in young women: controlled, open, partly randomized investigation over 13 cycles. Contraception 2006 0.76
104 Vertebral fracture diagnosis in the multinational BONE study of oral ibandronate: quality management in radiology. J Clin Densitom 2007 0.75
105 Comment on Putting evidence-based medicine into clinical practice: comparing anti-resorptive agents for the treatment of osteoporosis. Curr Med Res Opin 2004 0.75
106 Enhanced physiological tremor deteriorates plantar flexor torque steadiness after bed rest. J Electromyogr Kinesiol 2010 0.75
107 Insights into coronary collateral formation from a novel porcine semiacute infarction model. Coron Artery Dis 2017 0.75
108 Hypertrophy and Explosive-Reactive Functioning in Sedentary Men following 10-weeks of Whole-Body Vibration. J Strength Cond Res 2016 0.75
109 Exercise and Transversus Abdominis Muscle Atrophy after 60 d Bed Rest. Med Sci Sports Exerc 2016 0.75
110 Effects Of 8-week Bed Rest With Resistance Training On Intramuscular And Subcutaneous Adipose Tissues In Humans: 1963 Board #115 June 2, 3: 30 PM - 5: 00 PM. Med Sci Sports Exerc 2016 0.75
111 The effect of continuous oestradiol with intermittent norgestimate on bone mineral density and bone turnover in post-menopausal women. Maturitas 2004 0.75
112 Comparison of bone loss with changes of bone architecture at six different skeletal sites using measures of complexity. J Gravit Physiol 2002 0.75